News

Anton Lavrentyev spoke at  the RBC-TV online conference dedicated to anti-crisis solutions for busines after COVID 19.

The application for participation in the Startup-Rally 2020 for pharmaceutical and healthcare projects is open.

The EDC platform, developed by Primer Capital's porfolio company, Data MATRIX, formed part of the list of recommended solutions in the official address to the Prime Minister of Russia.

Primer Capital's porfolio unit, Data MATRIX announced today that it is to offer free Electronic Data Capture (EDC) for companies running COVID-19 trials.

February 21, Anton Lavrentyev, the CEO of Primer Capital participated in a panel discussion on Investing in AI within the OpenTalks.AI conference.

Read another blog piece by Anton Lavrentev, Primer Capital CEO for VC.ro on 6 lifehacks on how to work with start-ups.

Primer Capital founders, Dmitry Sharov and Timur Avdeenko shared the story of the fund in a feature story by Forbes Russia.

Primer Capital COO Elizaveta Rozhdestvenskaya spoke at the round table on Investing in Science during the III International Medical Investment Forum 2019.

Acticor Biotech, Primer Capital's portfolio unit, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, including acute ischemic stroke, today announced that it has raised €7 million in addition to its Series B which is now completed at €22,3 million.

In her interview for Rusbase Primer Capital COO Elizaveta Rozhdenstvenskaya shared her thoughts on the pharma and biotech startups and the overall venture market trends.